Past Events 2020-21
Eyecelerator
Targeting Vision Improvement with Risuteganib in Intermediate Dry AMD
Presented by Vicken Karageozian, M.D.
November 11, 2021
Dry AMD Therapeutic Development Summit
Targeting Vision Improvement with Risuteganib in Intermediate Dry AMD
Presented by Vicken Karageozian, M.D.
October 19-21, 2021
ASCRS ASOA
Prospective, Randomized, Double-masked, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Topical Risuteganib (ALG-1007) for the Treatment of Dry Eye Disease
Presented by Eric D. Donnenfeld, M.D.
July 24, 2021
Eyecelerator
Oxidative Stress Stabilizers for the Treatment of Ocular Diseases
Presented by Vicken Karageozian, M.D.
July 22, 2021
2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 1-7, 2021 – Virtual
For more information, including a list of presentations, click here.
American Society of Retina Specialists (ASRS) 2020 Virtual
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-related Macular Degeneration
Presented by Justis Ehlers, MD
July 26, 2020
WOC 2020 Virtual
Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration
Presented by Peter K. Kaiser, MD
June 26-29, 2020
Macula Society
Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration
Presented by Glenn J. Jaffe, MD
February 20, 2020
San Diego, CA
Angiogenesis, Exudation, and Degeneration 2020
Risuteganib for the Treatment of Dry AMD: Structure/Function Correlations
Presented by Glenn J. Jaffe, MD
February 8, 2020
Miami, FL
Phase 2 Study Results of Risuteganib in Dry AMD
Presented by Peter K. Kaiser, MD
February 8, 2020
Miami, FL
